Disease-modifying treatment

Last updated

A disease-modifying drug, or disease-modifying therapy, is a treatment that delays, slows or reverses the progression of a disease by targeting its underlying cause. [1] They are distinguished from symptomatic treatments that treat the symptoms of a disease but do not address its underlying cause. [2]

Examples

References

  1. ↑ McFarthing, Kevin; Rafaloff, Gary; Baptista, Marco; Mursaleen, Leah; Fuest, Rosie; Wyse, Richard K.; Stott, Simon R.W. (2022-05-24). "Parkinson's Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update". Journal of Parkinson's Disease. 12 (4): 1073–1082. doi:10.3233/JPD-229002. PMC   9198738 . PMID   35527571.
  2. ↑ "Symptomatic Versus Disease-Modifying Therapies for Movement Disorders - Parkinson's and Movement Disorder Foundation". pmdf.org. Retrieved 2022-09-11.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.